|
|
Other links at Articles > Dermatology |
| 3. |
Sorafenib Plus Dacarbazine Shows Promise in Advanced Melanoma
|
|
|
In a phase II study of chemotherapy-naive patients with stage III (unresectable) or stage IV melanoma, the addition of the Raf kinase inhibitor sorafenib to dacarbazine yielded an "encouraging" improvement in progression-free survival, the primary endpoint, and was well tolerated, researchers report. Reuters Health Information
|
| 5. |
Alefacept Produces Lasting Psoriasis Relief for Some
|
|
|
Alefacept, which in 2003 was the first biologic agent approved in the US for the treatment of moderate to severe chronic plaque psoriasis, appears to be a long-term option for certain patients. Reuters Health Information
|
|
|